Reasons for not participating in a phase 1 preventive HIV vaccine study in a resource-rich country

AIDS Patient Care and STDs

Volumn 26, Issue 7, 2012, Pages 379-382

  Lucero, Maria Constanza ^a   Diaz Brito, Vicens ^a   Murillo, Berta Torres ^a   Carretero, Saray Corral ^b   Sala, Marta ^a   Casadesús, Cristina ^a   Conde, Matilde Sanchez ^b   Jimenez, Jose Luis ^b   Pich, Judit ^a   Arnaiz, Joan Albert ^a   Leon, Agathe ^a   Perez, Iñaki ^a   Muñoz Fernández, M Ángeles ^b   Gatell, Jose M ^a   Plana, Montserrat ^a   Esteban, Mariano ^c   Bernaldo De Quiros, Juan Carlos ^b   Garcia, Felipe ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CONDOM; CONTRACEPTION; CONTROLLED STUDY; DEMOGRAPHY; E-MAIL; FEMALE; HIGH RISK BEHAVIOR; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; INFORMED CONSENT; INSTITUTIONAL ETHICS; INSTITUTIONAL REVIEW; LETTER; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; MEDICAL LITERATURE; OPEN ENDED QUESTIONNAIRE; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SEXUAL BEHAVIOR; SPAIN; STATISTICS; TELEPHONE; VOLUNTEER;

ADULT; AIDS VACCINES; CLINICAL TRIALS, PHASE I AS TOPIC; FEMALE; HIV INFECTIONS; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; MALE; MOTIVATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84864667477     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0086     Document Type: Letter

References (12)

1. UNAIDS 2011.World AIDSDayreport: November 2011.UNAIDS/JC2216E Last accessedMay 62012)www.unaids.org/en/media/unaids/contentassets/documents/ unaidspublication/2011/JC2216-WorldAIDSday-report-2011-en.pdf (Last accessed May 6, 2012).
2. Klausner RD, Fauci AS, Corey L, et al. The need for a global HIV vaccine enterprise. Science 2003;300:2036-2039.
3. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209-2220.
4. Newman PA, Duan N, Lee SJ, et al. Willingness to participate in HIV vaccine trials: The impact of trial attributes. Prev Med 2007;44(6):554-7.
5. Gray K, Legg K, Sharp A, et al. Participation in two phase II prophylactic HIV vaccine trials in the UK. Vaccine 2008;26: 2919-2924.
6. García F, Bernaldo De Quiró s JC, Gómez CE, et al. Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02). Vaccine 2011; 29:8309-8316.
7. Gómez CE, Nájera JL, Perdiguero B, et al. The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional and selective effector memory T cell responses to HIV-1 antigens. J Virol 2011;85:11468-11478.
8. Buchbinder SP, Metch B, Holte SE, et al. Determinants of enrollment in a preventive HIV vaccine trial. J Acquir Immune Defic Syndr 2004;36:604-612.
9. Ruzagira E, Wandiembe S, Bufumbo L, Levin J, et al. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health 2009;14:196-203.
10. Tarimo EA, Thorson A, Kohi TW, et al. Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania. PLoS One 2011;6:e14619.
11. Thapinta D, Jenkins RA, Morgan PA, et al. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr 2002;30: 503-513.
12. Floyd T, Patel S, Weiss E, Zaid-Muhammad S, Lounsbury D, Rapkin B. Beliefs about participating in research among a sample of minority persons living with HIV/AIDS in New York City. AIDS Patient Care STDs 2010; 24:373-380.